Merck KGaA (XBUL:MRK) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:MRK Merck KGaA XBUL:MRK
84 GF Score
Price лв114.65
GF Value лв118.39
! 10 Warning Signs
View Full Analysis

What is Merck KGaA FFO?

FFO (Funds from operations) only applies to REITs.

XBUL:MRK
84GF Score
Merck KGaA XBUL:MRK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck KGaA (XBUL:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued. The current stock price of лв114.65 is trading 3.2% below its estimated GF Value™ of лв118.39.

Key valuation signals for XBUL:MRK:

  • FFO:
  • GF Value™: лв118.39 vs. price of лв114.65 (3.2% below fair value)
  • GF Score™: 84/100 with 10 warning signs

No single metric tells the full story. See the XBUL:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
84GF Score

Get the complete analysis for XBUL:MRK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

лв114.65
Price
лв118.39
GF Value